| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.0B | $7.1B | $8.3B | $8.3B | $6.7B | $1.4B | $1.4B | $1.5B |
| Cost of Revenue | $4.0B | $3.9B | $4.4B | $4.2B | $4.0B | $3.5B | $3.5B | $3.6B |
| Gross Profit | $2.0B | $3.2B | $3.9B | $4.1B | $2.7B | $0.5B | $0.5B | $0.6B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.1B | $1.8B | $2.5B | $2.4B | $1.3B | $0.3B | $0.4B | $0.8B |
| Net Income | $0.1B | $1.6B | $2.2B | $1.9B | $1.0B | $0.1B | $0.1B | $0.2B |
| EPS (Basic) | $0.29 | $3.68 | $5.07 | $4.39 | $2.37 | $0.57 | $0.52 | $1.48 |
| EPS (Diluted) | $0.29 | $3.63 | $4.89 | $4.25 | $2.27 | $0.21 | $0.14 | $0.39 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.5B | $14.1B | $13.2B | $12.0B | $9.6B | $8.7B | $8.4B | $7.6B |
| Current Assets | $5.8B | $6.8B | $5.9B | $5.7B | $3.8B | $3.2B | $3.0B | $3.2B |
| Cash & Equivalents | $2.1B | $2.7B | $2.5B | $2.9B | $1.4B | $1.1B | $0.9B | $1.1B |
| Total Liabilities | $4.8B | $5.3B | $5.4B | $5.8B | $5.0B | $5.1B | $5.1B | $4.4B |
| Current Liabilities | $1.3B | $1.3B | $2.2B | $2.1B | $1.5B | $1.7B | $1.8B | $1.5B |
| Stockholders' Equity | $7.7B | $8.8B | $7.8B | $6.2B | $4.6B | $3.5B | $3.3B | $3.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.8B | $1.9B | $2.0B | $2.6B | $1.8B | $0.9B | $0.7B | $1.3B |
| Investing Cash Flow | $-0.5B | $-1.0B | $-1.7B | $-0.7B | $-0.9B | $-0.5B | $-1.5B | $-0.5B |
| Capital Expenditures | $0.3B | $0.7B | $1.6B | $1.0B | $0.4B | $0.4B | $0.5B | $0.5B |
| Financing Cash Flow | $-1.8B | $-0.7B | $-0.7B | $-0.4B | $-0.6B | $-0.2B | $0.6B | $-0.6B |